The National Heart, Lung, and Blood Institute (NHLBI) announced Tuesday a plan to issue a "Program Announcement" in April 2007 for investigator-initiated Phase II/III multi-site, randomized, controlled clinical trial grant applications.

The AASM will report details of the program when more information becomes available.